BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 18, 2017
View Archived Issues
DerG-PG70 LEAPS vaccine suppresses arthritis progression in two Th1 cell-driven murine models
Read More
Exenatide has positive effects on motor scores in patients with Parkinson's disease
Read More
Promising preclinical data for novel pan-MMP inhibitor-based tracer [99mTc]RYM-1
Read More
Cambridge Epigenetix and NuGEN partner to combine leading technologies in epigenetics research
Read More
First patient enrolled in phase I study of OTS-167 in breast cancer
Read More
Aradigm receives grant to study products in pulmonary non-tuberculous mycobacteria
Read More
Medshine Discovery, Jiangsu Chia Tai Tianqing Pharmaceutical patent bile acid receptor agonists
Read More
Prometic Life Sciences finalizes joint venture with affiliates of Shenzhen Royal Asset Management
Read More
Context Therapeutics enters into collaboration agreements to study Sigma1 protein
Read More
Protalex awarded grant to support development of PRTX-100
Read More
First patient dosed in phase I/II study of birinapant in combination with Keytruda in solid tumors
Read More
Medivir licenses exclusive rights for MIV-802 to Ascletis in greater China
Read More
ViraCyte receives CPRIT grant from the Cancer Prevention and Research Institute of Texas
Read More
Tetraphase Pharmaceuticals submits marketing application for i.v. eravacycline in Europe
Read More
FDA approves Besponsa for adults with relapsed or refractory ALL
Read More
First patient dosed in phase I study of UCART-123 in BPDCN
Read More
Avadel and Serenity enter into exclusive negotiations for Noctiva
Read More
FDA grants new ovarian cancer approvals for Lynparza
Read More
Gilead Sciences Canada receives approval notice for Vosevi in refractory HCV
Read More
Response submitted to FDA's complete response letter for latanoprostene bunod
Read More
Health Canada approves Maviret for chronic HCV in all major genotypes
Read More
Hikma expands licensing agreement with Takeda for new products in the Middle East and North Africa
Read More